Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W A Craig

Showing results (141-150 of 162) with videos related to

Pageof 17
Sort By:
Annals of Internal Medicine|November 1, 1978
Hospital use of antimicrobial drugs. Survey at 19 hospitals and results of antimicrobial control programW A Craig, S J Uman, W R Shaw, et al.
Infection and Immunity|April 1, 1988
Lipid X protects mice against fatal Escherichia coli infectionD T Golenbock, J E Leggett, P Rasmussen, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1981
Pharmacokinetics of cefuroxime in normal and impaired renal function: comparison of high-pressure liquid chromatography and microbiological assaysR W Bundtzen, R D Toothaker, O S Nielson, et al.
The Journal of Infectious Diseases|February 1, 1989
Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection modelsJ E Leggett, B Fantin, S Ebert, et al.
Journal of Pharmaceutical Sciences|November 1, 1982
Bioavailability of tolazamide from tablets: comparison of in vitro and in vivo resultsP G Welling, R B Patel, U R Patel, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1983
Pharmacokinetics of piperacillin in subjects with various degrees of renal functionP G Welling, W A Craig, R W Bundtzen, et al.
Infection|January 1, 1980
Cefotaxime pharmacokinetics following a single intravenous dose to patients with varying renal functionO S Nielsen, R D Toothaker, R W Bundtzen, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1988
Pharmacokinetics and pharmacodynamics of cefoperazone-sulbactam in patients on continuous ambulatory peritoneal dialysisC A Johnson, S W Zimmerman, D P Reitberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 1997
Practice guidelines for community-based parenteral anti-infective therapy. ISDA Practice Guidelines CommitteeD N Williams, S J Rehm, A D Tice, et al.
Antimicrobial Agents and Chemotherapy|March 18, 2000
In vivo pharmacodynamic activities of two glycylcyclines (GAR-936 and WAY 152,288) against various gram-positive and gram-negative bacteriaM L van Ogtrop, D Andes, T J Stamstad, et al.
Pageof 17

Showing results (141-150 of 162) with videos related to

Sort By:
Pageof 17
Annals of Internal Medicine|November 1, 1978
Hospital use of antimicrobial drugs. Survey at 19 hospitals and results of antimicrobial control programW A Craig, S J Uman, W R Shaw, et al.
Infection and Immunity|April 1, 1988
Lipid X protects mice against fatal Escherichia coli infectionD T Golenbock, J E Leggett, P Rasmussen, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1981
Pharmacokinetics of cefuroxime in normal and impaired renal function: comparison of high-pressure liquid chromatography and microbiological assaysR W Bundtzen, R D Toothaker, O S Nielson, et al.
The Journal of Infectious Diseases|February 1, 1989
Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection modelsJ E Leggett, B Fantin, S Ebert, et al.
Journal of Pharmaceutical Sciences|November 1, 1982
Bioavailability of tolazamide from tablets: comparison of in vitro and in vivo resultsP G Welling, R B Patel, U R Patel, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1983
Pharmacokinetics of piperacillin in subjects with various degrees of renal functionP G Welling, W A Craig, R W Bundtzen, et al.
Infection|January 1, 1980
Cefotaxime pharmacokinetics following a single intravenous dose to patients with varying renal functionO S Nielsen, R D Toothaker, R W Bundtzen, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1988
Pharmacokinetics and pharmacodynamics of cefoperazone-sulbactam in patients on continuous ambulatory peritoneal dialysisC A Johnson, S W Zimmerman, D P Reitberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 1997
Practice guidelines for community-based parenteral anti-infective therapy. ISDA Practice Guidelines CommitteeD N Williams, S J Rehm, A D Tice, et al.
Antimicrobial Agents and Chemotherapy|March 18, 2000
In vivo pharmacodynamic activities of two glycylcyclines (GAR-936 and WAY 152,288) against various gram-positive and gram-negative bacteriaM L van Ogtrop, D Andes, T J Stamstad, et al.
Pageof 17